| Literature DB >> 31749903 |
Brian Cox1,2, Kevin I Booker-Milburn3,4, Luke D Elliott3, Michael Robertson-Ralph4, Victor Zdorichenko2.
Abstract
Pressure on researchers to deliver new medicines to the patient continues to grow. Attrition rates in the research and development process present a significant challenge to the viability of the current model of drug discovery. Analysis shows that increasing the three-dimensionality of potential drug candidates decreases the risk of attrition, and it is for this reason many workers have taken a new look at the power of photochemistry, in particular photocycloadditions, as a means to generate novel sp3-rich scaffolds for use in drug discovery programs. The viability of carrying out photochemical reactions on scale is also being addressed by the introduction of new technical developments.Entities:
Year: 2019 PMID: 31749903 PMCID: PMC6862337 DOI: 10.1021/acsmedchemlett.9b00409
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345